CSL - Current Liabilities


CSL reported $4.61B in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Arca Biopharma USD 31.78M 8.81M Sep/2026
aTyr Pharma USD 16.46M 5.07M Sep/2026
Bio Path USD 9.15M 468K Mar/2026
Brainstorm Cell Therapeutics USD 12.38M 621K Jun/2026
Cara Therapeutics USD 8.08M 3.18M Sep/2026
CSL USD 4.61B 207M Dec/2025
Curis USD 14.97M 898K Mar/2026
Immunic USD 31.55M 290K Sep/2026
Minerva Neurosciences USD 2.29M 381K Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
TherapeuticsMD USD 5.82M 655K Jun/2024